Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

about

Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

Item

http://www.wikidata.org/entity/Q36035257

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

@ast

Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

@en

type

Item

label

Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

@ast

Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

@en

prefLabel

Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

@ast

Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

@en

P1476

Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.

@en

P2093

James S Kalus

http://www.w3.org/2001/XMLSchema#string

Lynette R Moser

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study

From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Update on intravenous fibrinolytic therapy for acute myocardial infarction.

Low-molecular-weight heparins.

The role of low-molecular-weight heparin in cardiovascular diseases.

Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.

Antithrombotic therapy for acute myocardial infarction.

Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?

P304

481-491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1E177

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8030688

http://www.w3.org/2001/XMLSchema#string

P698

15701782

http://www.w3.org/2001/XMLSchema#string